Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czechia
Cyprus
Denmark
Estonia
Germany
Hungary
Italy
Kosowo
Latvia
Lithuania
Luxembourg
Macedonia
Montenegro
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom
Hong Kong
Kuwait
Lebanon
UAE
RSA
VITA 34 International AG: VITA 34 revises sales forecast for 2009 / Profit is expected to break even as planned
Leipzig, December 16, 2008 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the
Read more
Investor News
Go to section:
-
-
VITA 34 International AG: VITA 34 International AG reporting record results both in storage and revenues. Results in line with expectations Leipzig, 13 October 2008 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading Read more
-
VITA 34 International AG: Diabetes Research Institute received IND approval for a clinical study in newly manifested Type 1 Diabetes children using autologous ‘Nabelschnurblut VITA34’ Leipzig, August 11, 2008 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading Read more
-
VITA 34 International AG: Preliminary figures and revised forecast for turnover and storages Leipzig, July 11, 2008 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading Read more
-
VITA 34 revenues and profits for 2007 better than expected VITA 34 revenues and profits for 2007 better than expected • Revenue up 33% to € 15.4 million • Storages Read more
Registration for our Email Service
You can register to be on the distribution list for our IR news with the following contact form in order to receive our latest publications and other notifications.